Supemtek Tetra

Influenza vaccine, recombinant, multivalent (H1N1, H3N2, B Victoria lineage, B Yamagata lineage) · Sanofi Winthrop Industrie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Supemtek Tetra, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: EMA Authorised: Supemtek Tetra (previously Supemtek) (Influenza A virus subtype H1N1 haemagglutinin, recombinant;Influenza A virus subtype H3N2 haemagglutinin, recombinant;Influenza B virus Victoria lineage haemagglutinin, recombinant;Influenza B virus Yamagata lineage haemagglutinin, recombinant) — Sanofi Winthrop Industrie

See pricing